In vivo demonstration in humans that large postprandial triglyceride- rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 11, 1996, Pages 1333-1339

  Silveira, Angela ^a,d   Karpe, Fredrik ^a   Johnsson, Hans ^a   Bauer, Kenneth A ^b,c   Hamsten, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

alimentary lipemia; factor IX; factor VII; factor XI; factor XII

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; LIPOPROTEIN; PROTHROMBIN; THROMBIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; HUMAN; HYPERLIPIDEMIA; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0029910844     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.11.1333     Document Type: Article

References (46)

1. Fair DS. Quantitation of factor VII in plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood. 1983;62:784-791.
2. Seligsohn U, Kasper CK, Østerud B, Rapaport SI. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood. 1979;53:828-837.
3. Miller BC, Hultin MB, Jesty J. Altered factor VII activity in hemophilia. Blood. 1985;65:845-849.
4. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry. 1991;30:10819-10824.
5. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood. 1992;80:25-28.
6. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993;81:734-744.
7. Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977;74:5260-5264.
8. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood. 1990; 76:731-736.
9. ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest. 1993;92:1207-1212.
10. Josso F, Prou-Wartelle O. Interaction of tissue factor and factor VII at the earliest phase of coagulation. Thromb Diath Haemorrh. 1965(suppl 17):35-44.
11. Nossel HL. Activation of factors XII (Hageman) and XI (PTA) by skin contact. Proc Soc Exp Biol Med. 1966;122:16-17.
12. Radcliffe R, Nemerson Y. Activation and control of factor VII by activated factor X and thrombin: isolation and characterization of a single chain form of factor VII. J Biol Chem. 1975;250:388-395.
13. Kisiel W, Fujikawa K, Davie EW. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). Biochemistry. 1977;16:4189-4194.
14. Radcliffe R, Bagdasarian A, Colman R, Nemerson Y. Activation of bovine factor VII by Hageman factor fragments. Blood. 1977; 50:611-617.
15. Seligsohn U, Østerud B, Brown SF, Griffin JH, Rapaport SI. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein and activated factor XII. J Clin Invest. 1979;64:1056-1065.
16. Soulier J-P, Prou-Wartelle O. New data on Hageman factor and plasma thromboplastin antecedent: the role of "contact" in the initial phase of blood coagulation. Br J Haematol. 1960;6:88-101.
17. Altman R, Hemker HC. Contact activation in the extrinsic blood clotting system. Thromb Diath Haemorrh. 1967;18:525-531.
18. Mitropoulos KA, Reeves BEA, O'Brien DP, Cooper JA, Martin JC. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface. Blood Coagul Fibrinolysis. 1993;4:223-234.
19. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW. Association between dietary fat intake and plasma factor VII coagulant activity: a predictor of cardiovascular mortality. Atherosclerosis. 1986;60:269-277.
20. Mitropoulos KA, Esnouf MP, Meade TW. Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia: evidence for increased conversion of VII to αVIIa and higher flux within the coagulation pathway. Atherosclerosis. 1987;63:43-52.
21. Marckman P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis. 1990;80:227-233.
22. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis. 1991;86:163-171.
23. Connelly JB, Roderick PJ, Cooper JA, Meade TW, Miller GJ. Positive association between self-reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart disease, in 4246 middle-aged men. Thromb Haemost. 1993;70:250-252.
24. Bladbjerg EM, Marckman P, Sandström B, Jespersen J. Nonfasting factor VII coagulant activity (FVII:C) increased by high fat diet. Thromb Haemost. 1994;71:755-758.
25. Mitropoulos KA, Martin JC, Burgess AI, Esnouf MP, Stirling Y, Howarth DJ, Reeves BEA. The increased rate of activation of factor I in late pregnancy can contribute to the increased reactivity of factor VII. Thromb Haemost. 1990;63:349-355.
26. Mitropoulos KA, Reeves BEA, Miller GJ. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins. Blood Coagul Fibrinolysis. 1993;4:943-951.
27. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis. 1992;95: 119-125.
28. Mitropoulos KA, Miller GJ, Howarth DJ, Reeves BEA, Cooper JA. The effects of intravenous Triton WR-1339 on factor VII coagulant activity and plasma lipoproteins in normocholesterolaemic and hypercholesterolaemic rabbits. Blood Coagul Fibrinolysis. 1994;5: 583-591.
29. Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb. 1994;14:214-222.
30. Silveira A, Green F, Karpe F, Blombäck M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost. 1994;72:734-739.
31. Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscier Thromb. 1994;14:60-69.
32. Baumstark MW, Berg A, Halle M, Keul J. Isoelectric focusing of apolipoproteins in immobilized pH gradients: improved determination of apolipoprotein E phenotypes. Electrophoresis. 1988;9: 576-579.
33. Karpe F, Bell M, Björkegren J, Hamsten A. Quantification of post-prandial triglyceride-rich lipoproteins in healthy men by retinyl ester labelling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler Thromb Vasc Biol. 1995;15:199-207.
34. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest. 1993;91:748-758.
35. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscier Thromb. 1991; 11:540-546.
36. Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscier Thromb. 1994;14:193-198.
37. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
38. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
39. Karpe F, Hamsten A. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res. 1994;35:1311-1317.
40. Carlson K. Lipoprotein fractionation. J Clin Pathol. 1973;5(suppl 26):32-37.
41. Zlatkis A, Zak B, Boyle A. A new method for direct determination of serum cholesterol. J Lab Clin Med. 1953;41:486-492.
42. Fletcher MJ. A colorimetric method for estimating serum triglycerides. Clin Chim Acta. 1968;22:393-397.
43. Carlson LA. Determination of serum triglycerides. J Atheroscler Res. 1963;3:334-336.
44. Eichinger S, Mannucci PM, Tradati F, Arbini AA, Rosenberg RD, Bauer KA. Determinants of plasma factor Vila levels in humans. Blood. 1995;86:3021-3025.
45. Taskinen M-R, Kuusi T. Enzymes involved in triglyceride hydrolysis. Baillieres Clin Endocrinol Metab. 1987;1:639-664.
46. Kelleher CC, Mitropoulos KA, Imeson J, Meade TW, Martin JC, Reeves BEA, Hughes LO. Hageman factor and risk of myocardial infarction in middle-aged men. Atherosclerosis. 1992;97:67-73.